[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Intravenous General Anesthetics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

July 2023 | 112 pages | ID: G58DB0813131EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Intravenous General Anesthetics market size was valued at USD 5721 million in 2022 and is forecast to a readjusted size of USD 7289.4 million by 2029 with a CAGR of 3.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Intravenous anesthesia is administered through a vein to provide general anesthesia.

This report is a detailed and comprehensive analysis for global Intravenous General Anesthetics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Intravenous General Anesthetics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Intravenous General Anesthetics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Intravenous General Anesthetics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Intravenous General Anesthetics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Intravenous General Anesthetics

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Intravenous General Anesthetics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare and B. Braun Melsungen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Intravenous General Anesthetics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Sedative
  • Analgesics
  • Muscle Relaxants
Market segment by Application
  • Hospital
  • Clinic
Major players covered
  • AstraZeneca
  • Fresenius-Kabi
  • AbbVie
  • Baxter Healthcare
  • B. Braun Melsungen
  • Liaoning Haisco
  • Pfizer
  • Teva Pharmaceutical Industries
  • Fresenius Kabi AG
  • SGPharma
  • Jiangsu Nhua Pharmaceutical Co., Ltd.
  • Xi'an Libang Pharmaceutical Co., Ltd.
  • Baxter international
  • Sichuan Guorui Pharmaceutical Co., Ltd.
  • Hikma
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Intravenous General Anesthetics product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Intravenous General Anesthetics, with price, sales, revenue and global market share of Intravenous General Anesthetics from 2018 to 2023.

Chapter 3, the Intravenous General Anesthetics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Intravenous General Anesthetics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intravenous General Anesthetics market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Intravenous General Anesthetics.

Chapter 14 and 15, to describe Intravenous General Anesthetics sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Intravenous General Anesthetics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Intravenous General Anesthetics Consumption Value by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Sedative
  1.3.3 Analgesics
  1.3.4 Muscle Relaxants
1.4 Market Analysis by Application
  1.4.1 Overview: Global Intravenous General Anesthetics Consumption Value by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Hospital
  1.4.3 Clinic
1.5 Global Intravenous General Anesthetics Market Size & Forecast
  1.5.1 Global Intravenous General Anesthetics Consumption Value (2018 & 2022 & 2029)
  1.5.2 Global Intravenous General Anesthetics Sales Quantity (2018-2029)
  1.5.3 Global Intravenous General Anesthetics Average Price (2018-2029)

2 MANUFACTURERS PROFILES

2.1 AstraZeneca
  2.1.1 AstraZeneca Details
  2.1.2 AstraZeneca Major Business
  2.1.3 AstraZeneca Intravenous General Anesthetics Product and Services
  2.1.4 AstraZeneca Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 AstraZeneca Recent Developments/Updates
2.2 Fresenius-Kabi
  2.2.1 Fresenius-Kabi Details
  2.2.2 Fresenius-Kabi Major Business
  2.2.3 Fresenius-Kabi Intravenous General Anesthetics Product and Services
  2.2.4 Fresenius-Kabi Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Fresenius-Kabi Recent Developments/Updates
2.3 AbbVie
  2.3.1 AbbVie Details
  2.3.2 AbbVie Major Business
  2.3.3 AbbVie Intravenous General Anesthetics Product and Services
  2.3.4 AbbVie Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 AbbVie Recent Developments/Updates
2.4 Baxter Healthcare
  2.4.1 Baxter Healthcare Details
  2.4.2 Baxter Healthcare Major Business
  2.4.3 Baxter Healthcare Intravenous General Anesthetics Product and Services
  2.4.4 Baxter Healthcare Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Baxter Healthcare Recent Developments/Updates
2.5 B. Braun Melsungen
  2.5.1 B. Braun Melsungen Details
  2.5.2 B. Braun Melsungen Major Business
  2.5.3 B. Braun Melsungen Intravenous General Anesthetics Product and Services
  2.5.4 B. Braun Melsungen Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 B. Braun Melsungen Recent Developments/Updates
2.6 Liaoning Haisco
  2.6.1 Liaoning Haisco Details
  2.6.2 Liaoning Haisco Major Business
  2.6.3 Liaoning Haisco Intravenous General Anesthetics Product and Services
  2.6.4 Liaoning Haisco Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 Liaoning Haisco Recent Developments/Updates
2.7 Pfizer
  2.7.1 Pfizer Details
  2.7.2 Pfizer Major Business
  2.7.3 Pfizer Intravenous General Anesthetics Product and Services
  2.7.4 Pfizer Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 Pfizer Recent Developments/Updates
2.8 Teva Pharmaceutical Industries
  2.8.1 Teva Pharmaceutical Industries Details
  2.8.2 Teva Pharmaceutical Industries Major Business
  2.8.3 Teva Pharmaceutical Industries Intravenous General Anesthetics Product and Services
  2.8.4 Teva Pharmaceutical Industries Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.9 Fresenius Kabi AG
  2.9.1 Fresenius Kabi AG Details
  2.9.2 Fresenius Kabi AG Major Business
  2.9.3 Fresenius Kabi AG Intravenous General Anesthetics Product and Services
  2.9.4 Fresenius Kabi AG Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Fresenius Kabi AG Recent Developments/Updates
2.10 SGPharma
  2.10.1 SGPharma Details
  2.10.2 SGPharma Major Business
  2.10.3 SGPharma Intravenous General Anesthetics Product and Services
  2.10.4 SGPharma Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 SGPharma Recent Developments/Updates
2.11 Jiangsu Nhua Pharmaceutical Co., Ltd.
  2.11.1 Jiangsu Nhua Pharmaceutical Co., Ltd. Details
  2.11.2 Jiangsu Nhua Pharmaceutical Co., Ltd. Major Business
  2.11.3 Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
  2.11.4 Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.11.5 Jiangsu Nhua Pharmaceutical Co., Ltd. Recent Developments/Updates
2.12 Xi'an Libang Pharmaceutical Co., Ltd.
  2.12.1 Xi'an Libang Pharmaceutical Co., Ltd. Details
  2.12.2 Xi'an Libang Pharmaceutical Co., Ltd. Major Business
  2.12.3 Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
  2.12.4 Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.12.5 Xi'an Libang Pharmaceutical Co., Ltd. Recent Developments/Updates
2.13 Baxter international
  2.13.1 Baxter international Details
  2.13.2 Baxter international Major Business
  2.13.3 Baxter international Intravenous General Anesthetics Product and Services
  2.13.4 Baxter international Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.13.5 Baxter international Recent Developments/Updates
2.14 Sichuan Guorui Pharmaceutical Co., Ltd.
  2.14.1 Sichuan Guorui Pharmaceutical Co., Ltd. Details
  2.14.2 Sichuan Guorui Pharmaceutical Co., Ltd. Major Business
  2.14.3 Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
  2.14.4 Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.14.5 Sichuan Guorui Pharmaceutical Co., Ltd. Recent Developments/Updates
2.15 Hikma
  2.15.1 Hikma Details
  2.15.2 Hikma Major Business
  2.15.3 Hikma Intravenous General Anesthetics Product and Services
  2.15.4 Hikma Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.15.5 Hikma Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: INTRAVENOUS GENERAL ANESTHETICS BY MANUFACTURER

3.1 Global Intravenous General Anesthetics Sales Quantity by Manufacturer (2018-2023)
3.2 Global Intravenous General Anesthetics Revenue by Manufacturer (2018-2023)
3.3 Global Intravenous General Anesthetics Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
  3.4.1 Producer Shipments of Intravenous General Anesthetics by Manufacturer Revenue ($MM) and Market Share (%): 2022
  3.4.2 Top 3 Intravenous General Anesthetics Manufacturer Market Share in 2022
  3.4.2 Top 6 Intravenous General Anesthetics Manufacturer Market Share in 2022
3.5 Intravenous General Anesthetics Market: Overall Company Footprint Analysis
  3.5.1 Intravenous General Anesthetics Market: Region Footprint
  3.5.2 Intravenous General Anesthetics Market: Company Product Type Footprint
  3.5.3 Intravenous General Anesthetics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Intravenous General Anesthetics Market Size by Region
  4.1.1 Global Intravenous General Anesthetics Sales Quantity by Region (2018-2029)
  4.1.2 Global Intravenous General Anesthetics Consumption Value by Region (2018-2029)
  4.1.3 Global Intravenous General Anesthetics Average Price by Region (2018-2029)
4.2 North America Intravenous General Anesthetics Consumption Value (2018-2029)
4.3 Europe Intravenous General Anesthetics Consumption Value (2018-2029)
4.4 Asia-Pacific Intravenous General Anesthetics Consumption Value (2018-2029)
4.5 South America Intravenous General Anesthetics Consumption Value (2018-2029)
4.6 Middle East and Africa Intravenous General Anesthetics Consumption Value (2018-2029)

5 MARKET SEGMENT BY TYPE

5.1 Global Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
5.2 Global Intravenous General Anesthetics Consumption Value by Type (2018-2029)
5.3 Global Intravenous General Anesthetics Average Price by Type (2018-2029)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
6.2 Global Intravenous General Anesthetics Consumption Value by Application (2018-2029)
6.3 Global Intravenous General Anesthetics Average Price by Application (2018-2029)

7 NORTH AMERICA

7.1 North America Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
7.2 North America Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
7.3 North America Intravenous General Anesthetics Market Size by Country
  7.3.1 North America Intravenous General Anesthetics Sales Quantity by Country (2018-2029)
  7.3.2 North America Intravenous General Anesthetics Consumption Value by Country (2018-2029)
  7.3.3 United States Market Size and Forecast (2018-2029)
  7.3.4 Canada Market Size and Forecast (2018-2029)
  7.3.5 Mexico Market Size and Forecast (2018-2029)

8 EUROPE

8.1 Europe Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
8.2 Europe Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
8.3 Europe Intravenous General Anesthetics Market Size by Country
  8.3.1 Europe Intravenous General Anesthetics Sales Quantity by Country (2018-2029)
  8.3.2 Europe Intravenous General Anesthetics Consumption Value by Country (2018-2029)
  8.3.3 Germany Market Size and Forecast (2018-2029)
  8.3.4 France Market Size and Forecast (2018-2029)
  8.3.5 United Kingdom Market Size and Forecast (2018-2029)
  8.3.6 Russia Market Size and Forecast (2018-2029)
  8.3.7 Italy Market Size and Forecast (2018-2029)

9 ASIA-PACIFIC

9.1 Asia-Pacific Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Intravenous General Anesthetics Market Size by Region
  9.3.1 Asia-Pacific Intravenous General Anesthetics Sales Quantity by Region (2018-2029)
  9.3.2 Asia-Pacific Intravenous General Anesthetics Consumption Value by Region (2018-2029)
  9.3.3 China Market Size and Forecast (2018-2029)
  9.3.4 Japan Market Size and Forecast (2018-2029)
  9.3.5 Korea Market Size and Forecast (2018-2029)
  9.3.6 India Market Size and Forecast (2018-2029)
  9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
  9.3.8 Australia Market Size and Forecast (2018-2029)

10 SOUTH AMERICA

10.1 South America Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
10.2 South America Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
10.3 South America Intravenous General Anesthetics Market Size by Country
  10.3.1 South America Intravenous General Anesthetics Sales Quantity by Country (2018-2029)
  10.3.2 South America Intravenous General Anesthetics Consumption Value by Country (2018-2029)
  10.3.3 Brazil Market Size and Forecast (2018-2029)
  10.3.4 Argentina Market Size and Forecast (2018-2029)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Intravenous General Anesthetics Market Size by Country
  11.3.1 Middle East & Africa Intravenous General Anesthetics Sales Quantity by Country (2018-2029)
  11.3.2 Middle East & Africa Intravenous General Anesthetics Consumption Value by Country (2018-2029)
  11.3.3 Turkey Market Size and Forecast (2018-2029)
  11.3.4 Egypt Market Size and Forecast (2018-2029)
  11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
  11.3.6 South Africa Market Size and Forecast (2018-2029)

12 MARKET DYNAMICS

12.1 Intravenous General Anesthetics Market Drivers
12.2 Intravenous General Anesthetics Market Restraints
12.3 Intravenous General Anesthetics Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
  12.5.1 Influence of COVID-19
  12.5.2 Influence of Russia-Ukraine War

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Intravenous General Anesthetics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intravenous General Anesthetics
13.3 Intravenous General Anesthetics Production Process
13.4 Intravenous General Anesthetics Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Intravenous General Anesthetics Typical Distributors
14.3 Intravenous General Anesthetics Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Intravenous General Anesthetics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Intravenous General Anesthetics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Intravenous General Anesthetics Product and Services
Table 6. AstraZeneca Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Fresenius-Kabi Basic Information, Manufacturing Base and Competitors
Table 9. Fresenius-Kabi Major Business
Table 10. Fresenius-Kabi Intravenous General Anesthetics Product and Services
Table 11. Fresenius-Kabi Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Fresenius-Kabi Recent Developments/Updates
Table 13. AbbVie Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Major Business
Table 15. AbbVie Intravenous General Anesthetics Product and Services
Table 16. AbbVie Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. AbbVie Recent Developments/Updates
Table 18. Baxter Healthcare Basic Information, Manufacturing Base and Competitors
Table 19. Baxter Healthcare Major Business
Table 20. Baxter Healthcare Intravenous General Anesthetics Product and Services
Table 21. Baxter Healthcare Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Baxter Healthcare Recent Developments/Updates
Table 23. B. Braun Melsungen Basic Information, Manufacturing Base and Competitors
Table 24. B. Braun Melsungen Major Business
Table 25. B. Braun Melsungen Intravenous General Anesthetics Product and Services
Table 26. B. Braun Melsungen Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. B. Braun Melsungen Recent Developments/Updates
Table 28. Liaoning Haisco Basic Information, Manufacturing Base and Competitors
Table 29. Liaoning Haisco Major Business
Table 30. Liaoning Haisco Intravenous General Anesthetics Product and Services
Table 31. Liaoning Haisco Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Liaoning Haisco Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Intravenous General Anesthetics Product and Services
Table 36. Pfizer Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 39. Teva Pharmaceutical Industries Major Business
Table 40. Teva Pharmaceutical Industries Intravenous General Anesthetics Product and Services
Table 41. Teva Pharmaceutical Industries Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Teva Pharmaceutical Industries Recent Developments/Updates
Table 43. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 44. Fresenius Kabi AG Major Business
Table 45. Fresenius Kabi AG Intravenous General Anesthetics Product and Services
Table 46. Fresenius Kabi AG Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Fresenius Kabi AG Recent Developments/Updates
Table 48. SGPharma Basic Information, Manufacturing Base and Competitors
Table 49. SGPharma Major Business
Table 50. SGPharma Intravenous General Anesthetics Product and Services
Table 51. SGPharma Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. SGPharma Recent Developments/Updates
Table 53. Jiangsu Nhua Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Jiangsu Nhua Pharmaceutical Co., Ltd. Major Business
Table 55. Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
Table 56. Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Jiangsu Nhua Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 58. Xi'an Libang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Xi'an Libang Pharmaceutical Co., Ltd. Major Business
Table 60. Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
Table 61. Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Xi'an Libang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 63. Baxter international Basic Information, Manufacturing Base and Competitors
Table 64. Baxter international Major Business
Table 65. Baxter international Intravenous General Anesthetics Product and Services
Table 66. Baxter international Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Baxter international Recent Developments/Updates
Table 68. Sichuan Guorui Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Sichuan Guorui Pharmaceutical Co., Ltd. Major Business
Table 70. Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
Table 71. Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Sichuan Guorui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 73. Hikma Basic Information, Manufacturing Base and Competitors
Table 74. Hikma Major Business
Table 75. Hikma Intravenous General Anesthetics Product and Services
Table 76. Hikma Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Hikma Recent Developments/Updates
Table 78. Global Intravenous General Anesthetics Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Intravenous General Anesthetics Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Intravenous General Anesthetics Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Intravenous General Anesthetics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Intravenous General Anesthetics Production Site of Key Manufacturer
Table 83. Intravenous General Anesthetics Market: Company Product Type Footprint
Table 84. Intravenous General Anesthetics Market: Company Product Application Footprint
Table 85. Intravenous General Anesthetics New Market Entrants and Barriers to Market Entry
Table 86. Intravenous General Anesthetics Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Intravenous General Anesthetics Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Intravenous General Anesthetics Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Intravenous General Anesthetics Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Intravenous General Anesthetics Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Intravenous General Anesthetics Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Intravenous General Anesthetics Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Intravenous General Anesthetics Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Intravenous General Anesthetics Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Intravenous General Anesthetics Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Intravenous General Anesthetics Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Intravenous General Anesthetics Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Intravenous General Anesthetics Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Intravenous General Anesthetics Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Intravenous General Anesthetics Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Intravenous General Anesthetics Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Intravenous General Anesthetics Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Intravenous General Anesthetics Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Intravenous General Anesthetics Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Intravenous General Anesthetics Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Intravenous General Anesthetics Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Intravenous General Anesthetics Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Intravenous General Anesthetics Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Intravenous General Anesthetics Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Intravenous General Anesthetics Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Intravenous General Anesthetics Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Intravenous General Anesthetics Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Intravenous General Anesthetics Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Intravenous General Anesthetics Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Intravenous General Anesthetics Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Intravenous General Anesthetics Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Intravenous General Anesthetics Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Intravenous General Anesthetics Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Intravenous General Anesthetics Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Intravenous General Anesthetics Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Intravenous General Anesthetics Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Intravenous General Anesthetics Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Intravenous General Anesthetics Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Intravenous General Anesthetics Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Intravenous General Anesthetics Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Intravenous General Anesthetics Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Intravenous General Anesthetics Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Intravenous General Anesthetics Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Intravenous General Anesthetics Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Intravenous General Anesthetics Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Intravenous General Anesthetics Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Intravenous General Anesthetics Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Intravenous General Anesthetics Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Intravenous General Anesthetics Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Intravenous General Anesthetics Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Intravenous General Anesthetics Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Intravenous General Anesthetics Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Intravenous General Anesthetics Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Intravenous General Anesthetics Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Intravenous General Anesthetics Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Intravenous General Anesthetics Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Intravenous General Anesthetics Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Intravenous General Anesthetics Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Intravenous General Anesthetics Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Intravenous General Anesthetics Raw Material
Table 146. Key Manufacturers of Intravenous General Anesthetics Raw Materials
Table 147. Intravenous General Anesthetics Typical Distributors
Table 148. Intravenous General Anesthetics Typical Customers

LIST OF FIGURES

Figure 1. Intravenous General Anesthetics Picture
Figure 2. Global Intravenous General Anesthetics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Intravenous General Anesthetics Consumption Value Market Share by Type in 2022
Figure 4. Sedative Examples
Figure 5. Analgesics Examples
Figure 6. Muscle Relaxants Examples
Figure 7. Global Intravenous General Anesthetics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Intravenous General Anesthetics Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Global Intravenous General Anesthetics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Intravenous General Anesthetics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Intravenous General Anesthetics Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Intravenous General Anesthetics Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Intravenous General Anesthetics Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Intravenous General Anesthetics Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Intravenous General Anesthetics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Intravenous General Anesthetics Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Intravenous General Anesthetics Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Intravenous General Anesthetics Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Intravenous General Anesthetics Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Intravenous General Anesthetics Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Intravenous General Anesthetics Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Intravenous General Anesthetics Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Intravenous General Anesthetics Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Intravenous General Anesthetics Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Intravenous General Anesthetics Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Intravenous General Anesthetics Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Intravenous General Anesthetics Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Intravenous General Anesthetics Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Intravenous General Anesthetics Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Intravenous General Anesthetics Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Intravenous General Anesthetics Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Intravenous General Anesthetics Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Intravenous General Anesthetics Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Intravenous General Anesthetics Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Intravenous General Anesthetics Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Intravenous General Anesthetics Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Intravenous General Anesthetics Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Intravenous General Anesthetics Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Intravenous General Anesthetics Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Intravenous General Anesthetics Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Intravenous General Anesthetics Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Intravenous General Anesthetics Consumption Value Market Share by Region (2018-2029)
Figure 53. China Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Intravenous General Anesthetics Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Intravenous General Anesthetics Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Intravenous General Anesthetics Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Intravenous General Anesthetics Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Intravenous General Anesthetics Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Intravenous General Anesthetics Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Intravenous General Anesthetics Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Intravenous General Anesthetics Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Intravenous General Anesthetics Market Drivers
Figure 74. Intravenous General Anesthetics Market Restraints
Figure 75. Intravenous General Anesthetics Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Intravenous General Anesthetics in 2022
Figure 78. Manufacturing Process Analysis of Intravenous General Anesthetics
Figure 79. Intravenous General Anesthetics Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


More Publications